PHYTOTEC WAS FOUNDED
Phytotec was founded in 1999 by Norbert Langen, at this time country manager of Bayer Pharma in Hungary. His idea was to bring modern evidence based herbal drugs from Germany and Switzerland to Hungary.
FIRST PRODUCT LAUNCHED
The first products were launched in 2001 in women’s health, promoted by a medical sales team visiting gynecologist – a concept new to the market
Over the years more herbal products followed produced by our German and Swiss partners (Schaper & Brümmer, Zeller AG) reaching market leading positions within a short time.
LAUNCH OF SEDACUR FORTE
Sedacur forte was launched in 2004. Today Sedacur leads the market of herbal sleeping and calming products.
START OF MEDICAL DEVICE BUSINESS
In 2008 Phytotec complemented its herbal drug portfolio with evidence based natural medical devices produced by Farma-Derma (Italy). Till today six medical devices were successfully launched in the areas of gynecology, urology and upper respiratory infections.
COOPERATION WITH VIFOR PHARMA
At the beginning of 2012 Phytotec signed a cooperation with Vifor Pharma the world leader in iron deficiency therapies. With Maltofer Phytotec entered the market of reimbursed RX products. Within a short time the product took over the market leader position in the oral iron replacement therapy. Other Rx products of Vifor followed.
In autumn of 2012 Phytotec started the promotion of Uro-Vaxom and Broncho-Vaxom licenced-in from OM Pharma, specialist in bacterial immunstimulating Rx drugs.
COOPERATION WITH BITOP AG
Since 2013 Phytotec cooperates with the German based bitop AG, bringing their innovative active ingredient Ectoin to the Hungarian market
FERINJECT – THE NEXT MILESTONE IN PHYTOTEC’S HISTORY
In 2017 Vifor and Phytotec expanded their successful cooperation to Ferinject, the world market leader in the iv. iron segment.
OTC SWITCH OF MALTOFER CHEW
At the end of 2018 Phytotec succesfully switched the regulatory status of Maltofer chew OTC being the first major EU market with OTC status
OPERATIV MANAGEMENT REORGANISED
In January 2019 the operative management of the direct to consumer communication (DTC) and the medical communication was split into two dedicated business units, due the increasing complexity and different promotional needs.
COOPERATION WITH URIACH GROUP
In August 2021 launch of the innovative
Colpofix gelspray for the treatment
and prevention of vaginal lesions caused by HPV
AN ORGANIZATION OF 40 MOTIVATED AND HIGHLY SKILLED EMPLOYEES
GUARANTEES THE GROWTH OF A PORTFOLIO OF 17 PRODUCTS